To validate these findings, a second measurement set confirmed the same trends: AMH remained lowest in the endometrioma group (1.32 ng/mL), followed by simple cysts (1.88 ng/mL) and dermoid cysts (2.13 ng/mL), compared to controls (3.05 ng/mL). This evidence concerns the gene AMH and dermoid cyst.